dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· January 31, 2026

The Sell-Off In Gold May Be Last Stop Before $10,000 – 5 Stocks and an ETF To Buy Now

View original at finance.yahoo.com
The Sell-Off In Gold May Be Last Stop Before $10,000 – 5 Stocks and an ETF To Buy Now The case for gold and gold miners is compelling for two reasons…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The demand for Gold will remain consistent over the next 5 to 10 years, according to some opinions from Wall Street

    80% confidence
  • Silver is not considered as much of an asset hedge or a store of value like gold

    80% confidence
  • In the long term, analysts expect gold to trade between $10,000 and $16,150 over the next 10 years

    80% confidence
  • Newmont Corporation rated Outperform

    80% confidence
  • Gold will reach $10,000 per ounce by 2028

    80% confidence
  • Wheaton Precious Metals rated Buy

    80% confidence
  • Franco-Nevada rated Buy

    80% confidence
  • The most powerful structural force is the global shift in reserve holdings, with central banks continuing to increase the percentage of gold in their international reserves

    80% confidence
  • Diversification away from U.S. dollar reserve holdings, while still moderate, has accelerated in recent years

    80% confidence
  • Agnico Eagle Mines rated Buy

    80% confidence
  • Barrick Gold rated Buy

    80% confidence
  • Gold will reach $5,000 per ounce by 2026

    80% confidence
  • Gold could reach $10,000 per ounce before the end of the decade if it continues on its current path

    80% confidence

Data points we hold from this source

UBS Group AG · target price270 USD
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
The Sell-Off In Gold May Be Last Stop Before $10,000 – 5 Stocks and an ETF To Buy Now: Source | Via News | fr.via.news